Business Development Director, Hudson River Biotechnology
BIOGRAPHY
DEC 08, 2021 9:00 AM PST
The MAD7™ nuclease in plant editing: overcoming CRISPR bottlenecks with MAD TiGER
Speakers
Event Date & Time
Date: December 8, 2021
Time: 9:00am (PST), 12:00am (EST)
Abstract
CRISPR editing has revolutionized plant breeding, and the MAD7 CRISPR nuclease developed by InscriptaTM is democratizing access to CRISPR technologies. Hudson River Biotechnology has developed a proprietary, validated molecular breeding workflow called MAD TiGER, which stands for Target identification, Guide selection, Entry into the cell and Regeneration using the MAD7 nuclease. MAD TiGER enables molecular breeding in an end-to-end fashion, providing innovative solutions to the typical barriers encountered in CRISPR plant breeding projects, such as cell entry and regeneration. The MAD TiGER workflow uses the MAD7 nuclease, nanotechnology and various synthetic gels to enable faster onset of cell divisions in regenerating and de-differentiating protoplasts towards micro-calli formation. During this webinar, Gabino Sanchez of Hudson River Biotechnology will provide an overview of the MAD TiGER workflow and discuss examples of using an integrated workflow for molecular breeding. You will also learn more about the MAD7 nuclease from Inscripta.
Learning Objectives
- Describe the current workflows for CRISPR-enabled plant breeding
- Recognize the technical barriers encountered in CRISPR breeding projects
- Demonstrate successful examples and the benefits of using integrated, technology-based workflow for molecular breeding
- Understand the commercial licensing options for MAD7 editing technologies
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...